Tag: T Cell

Oncotarget News

Behind the Study: CrkL Required for Donor T Cell Migration

February 18, 2022

Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor... read more

Oncotarget

Behind the Study: Metronomic Cyclophosphamide – Innate Immunity and Anti-Tumor Responses

February 1, 2021

Researcher Mary Janatpour describes the findings in a paper she helped author in Oncotarget titled, "Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate... read more